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Background
Rectal cancer is one of the most common malignancies
in the western world and in our albanian population (1).
The management of  rectal cancer has changed thoroughly
in recent years: advances in surgical technique, imaging
and adjuvant therapy have dramatically altered the way
patients are treated (2). 
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Rectal cancer is one of the most common malignancies in the we-
stern world population. The management of rectal cancer has changed
thoroughly in recent years owing to the rapid advances in surgical tech-
niques, imaging and adjuvant therapy.
The present study analyses extensively 152 patients operated for
diagnosis of, rectal cancer in the First Clinic of General Surgery  UHC
“Mother Theresa” in Tirana, Albania, in a ten years period. In the me-
dical and operative records were analysed demographic, diagnostic, cli-
nic, operative, pathology and postoperative patient’s data. 
M : F ratio was 1,5:1. The average age of all patients was 59,8 ±
12,2 (29 – 79) years. 48% of all patients were of the age group 61 –
70 years. The diagnosis interval was 6 ± 4,6 months. The mean di-
stance of tumor from the anal verge was 8,3 ± 4,2 (3,7 – 16) cm. 30%
of all patients resulted stage D, according to the Astler – Coller classifi-
cation. Overall operability index was 97,5%. 30 % of patients were
treated with palliative operative procedures. 67,5% of all patients we-
re treated with curative intent. The most common curative operation
was low anterior resection with mesorectal excision in 76 patients
(51%). The mean postoperative hospital stay was 12 ± 9,7 (3 – 45)
days. Overall postoperative morbidity and mortality were 30% and
2,6% respectively. 
The surgical treatment of rectal cancer has changed radically in re-
cent years in Albania. Relatively new surgical techniques, like low an-
terior resection and use of adjuvant chemoradiotherapy have improved
the outcome, quality of life and survival of our patients. 
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Il cancro del retto è una delle più comuni malattie maligne nella po-
polazione occidentale. Il trattamento del cancro del retto è cambiato ra-
dicalmente negli ultimi anni seguendo i repentini progressi delle tecniche
chirurgiche, della diagnostica per immagini e della terapia adiuvante.
Lo studio prende in esame 152 pazienti operati per cancro del ret-
to nella 1ª Clinica di Chirurgia Generale del Centro Ospedaliero Uni-
versitario “Madre Teresa” di Tirana, Albania in un periodo di dieci an-
ni. Nella documentazione medica sono stati analizzati dati demogra-
fici, diagnostici, clinici, operatori, patologici e post operatori.
La ratio M:F era di 1,5:1. L’età media dei pazienti era di 59,8 ±
12,2 (29 – 79) anni. 48% dei pazienti erano di età compresa tra 61
a 70 anni. L’intervallo di diagnosi era di 6± 4,6 mesi. La distanza me-
dia del tumore dal margine anale era di 8,3 ± 4,2 (3,7 – 16) cm. Il
30% dei pazienti risultava allo stadio D della malattia secondo la clas-
sificazione di Aster–Coller. L’indice globale di operabilità è stato del
97,5%. Il 30% dei pazienti è stato sottoposto a trattamenti chirurgici
palliativi. Il 67,5% dei pazienti è stato trattato con intento curativo.
L’intervento curativo più comune è stata la resezione anteriore del ret-
to con escissione del mesoretto, effettuata su 76 pazienti (51%). La de-
genza media ospedaliera post operatoria è stata di 12 ± 9,7 (3 – 45)
giorni. La morbilità e la mortalità globale sono state del  30% e del
2,6% rispettivamente.
Il trattamento chirurgico del cancro del retto in Albania negli ul-
timi anni è cambiato radicalmente. La resezione anteriore bassa e l’u-
tilizzo della chemioterapia adiuvante hanno portato a risultati positi-
vi sulla qualità della vita e sulla sopravivenza dei pazienti.
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Our present study aims to give a complete overview
of the surgical treatment of the patients with rectal can-
cer in the First Clinic of General Surgery UHC “Mother
Theresa” in Tirana, Albania in the past ten years.
Patients and methods
The medical and operative records of 152 consecutive patients
who undervent elective  surgery in the First Clinic of General Sur-
gery UHC “Mother Theresa” in Tirana, Albania for the diagnosis of
rectal cancer from January 1, 2000 till December 31, 2009 were analy-
sed and examined in detail.
The diagnosis and preoperative evaluation of rectal cancer was
made by colonoscopy, abdominal CT scan, chest X-ray  and biopsy.
Some patients were examined with barium enema, MRI and abdo-
minal/rectal ultrasound  (3).   
The localisation of the rectal tumor was classified using the ‘rule
of thirds’ (lower third 3,5 – 7,5 cm; middle third 7,5 – 12 cm and
upper third 12 – 16 cm from the anal verge) (4). The perioperative
staging of the the rectal carcinoma was based on the modified Astler
–Coller classification of the Dukes staging system for colorectal can-
cer (5) (Table 1).
Surgical procedures included low anterior operation, Hartmann
resection, abdominoperineal resection (Miles), palliative colostomy
and local excision. All anastomoses performed in the above mentioned
procedures were hand sewn.
Postoperative complications were defined as those occurring du-
ring hospitalization or within 30 days of surgery; including abdo-
minal and extraabdominal complications (6). Mortality was defined
as death occurring in the hospital (6, 7). Clinical leak was defined
as evidence of generalised or pelvic infection associated with symp-
toms as abdominal pain, fever, leucocytosis, or shock (6, 8). The leaka-
ge was confirmed by contrast enema, or CT scan or at reoperation.
Data are expressed as means ± SD (ranges). The statistical analy-
sis was made using Student test. Significance was defined as P < 0,05.
Results
From 2000 to 2009 (ten years), 152 patients un-
dervent elective surgery in the First Clinic of General Sur-
gery UHC “Mother Theresa” in Tirana, Albania, for the
diagnosis of rectal cancer. Demographic data of the pa-
tients are given in Table 2.
The anamnestic data (signs and symptoms) of all pa-
tients are given in Table 3. 
The diagnosis interval (time interval elapsed from the
onset of  signs and symptoms to correct diagnosis) was
6±4,6 (1 week – 16 months) months
The tumor characteristics of all patients are given in
Tables 4 and 5.
The mean distance of tumor from anal verge was 
8,3±4,2 (3,7–16) cm.
From 152 patients, 4 (2,5%) resulted inoperable at
the time of surgery. Overall operability index was
97,5%; 46 (30%) patients of advanced stages C3 and D
were treated with palliative operative procedures (Table
TABLE 1 - MODIFIED ASTLER-COLLER CLASSIFICA-
TION OF THE RECTAL CANCER (5).
Stage Description
A Lesion not penetrating submucosa
B1 Lesion invades but not through 
the muscularis propria
B2 Lesion through intestinal wall, 
no adjacent organ involvement.
B3 Lesion involves adjacent organs
C1 Lesion B1 invasion depth; 
regional lymph node metastasis
C2 Lesion B2 invasion depth; 
regional lymph node metastasis 
C3 Lesion B3 invasion depth; 
regional lymph node metastasis
D Distant metastatic disease
TABLE 2 - DEMOGRAPHIC DATA OF ALL PATIENTS (152).
* 68 patients (48%) were of the age group 61–70 years. Statistical
analysis using Student test resulted P = NS (non significant).
Sex
Males 92  (60%)
Females 60  (40%)
M : F ratio 1,5 : 1
Age (yrs)
Males 59,7 ± 10,5 (38 – 77)*
Females 60,3 ± 13,4 (29 – 79*
All patients 59,8 ± 12,2 (29 – 79)*
TABLE 3 - SIGNS AND SYMPTOMS OF ALL PATIENTS
(152).
Signs and symptoms Pts %
Pain 124 82
Weight loss 118 78
Mucous diarrhea 102 67
Constipation 96 63
Rectal bleeding 80 52
Tenesmus 34 22
Ileus 10 7
TABLE 4 - LOCALISATION AND MACROSCOPIC FEATU-
RE OF TUMOR (152 PTS).
Pts %
Localisation 
Upper third 64 42
Middle third 56 37
Lower third 32 21
Macroscopic feature
Ulcerative 67 44
Infiltrative (circular obstructing) 41 27
Polypoid 29 19
Mixed type 15 10
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6); 102 (67,5%) patients were treated with curative in-
tent shown in Table 7.
The postoperative hospital stay was 12±9,7 (3 – 45)
days. The postoperative hospital stay in three most perfor-
med operative procedures is shown in Table 8.
Histology of all resected specimen showed adeno-
carcinoma; well differentiated in 58%; mid differentia-
ted in 30%, undifferentiated in 12% of cases.
Overall postoperative morbidity was 30% (Table 9).
Overall mortality was 2,6% (4 patients in the po-
stoperative period).
Discussion
Preoperative evaluation of rectal cancer has become
inceasingly important to choose the optimum surgical
treatment and to obtain the best results and disease-free
survival (9). Our patients were examined and evaluated
with colonoscopy, abdominal CT scan, chest X-ray  and
biopsy and some of them with barium enema, MRI and
abdominal/rectal ultrasound (3, 9). In general, preope-
rative data agreed with the operative findings, but a major
drawback was the long time to reach the diagnosis (mean
6 months), with the consequence that 30% of patients
were stage D of Astler-Coller classification at the time
of diagnosis and was impossible to perform a curative re-
section in these patients. The demographic data of our
patients indicate clearly that rectal cancer is rare before
the fifth decade of life, with a slight preference for the
male sex (7, 10, 11). All the patients treated with local
excision of tumor were examined with rectal ultrasound
to asess the tumor spread through the rectal wall and the
involvement of perirectal lymph nodes (12). However,
the extent of local spread, tissue infiltration and lymph
node involvement was better defined by abdominal CT
scan and, occasionally MRI (2, 12). In our country, in
the past, cancers of the middle and distal rectum were
treated by abdominoperineal resection of the rectum, but
in the last 20 years these cancers have been treated in-
creasingly by low anterior resection, which avoids the need
for a permanent stoma (10, 13, 14). Seventy-six (50%)
patients undervent low anterior resection in our Clinic
with good results. For the high rectal cancer, rectal ex-
cision and mesorectal excision were performed at least
5 cm below the level of the tumor; for low and middle
rectal tumors a near-total mesorectal excision was
performed (14, 15). Total mesorectal excision had reduced
local recurrence following surgery to less than 15%,
without raising the anastomotic dehiscence rate (16). The
overall morbidity and anastomotic leakage rates of
30% and 7,2% respectively observed in our patients were
comparable to the rates reported by other authors (7, 10,
13, 14, 17, 18). Postoperative anal dilatation has been
used as a protective measure against the leakage at the
level of anastomosis (7, 14). In carefully selected patients,
particularly the elderly or those with severe co-morbi-
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TABLE 7 - CURATIVE SURGICAL TREATMENT OF REC-
TAL CANCER (102 PTS).
Procedure Pts %
Low anterior resection 76 74,5
Abdominoperineal resection 22 21,5
Local excision 4 4
TABLE 8 - POSTOPERATIVE HOSPITAL STAY OF DIFFE-
RENT OPERATIVE PROCEDURES (132 PTS).
* Statistical analysis using Student test resulted P = NS (non signifi -
cant).
Procedure Postoperative hospital stay (days)
Abdominoperineal resection 16 ± 12,6 (7 – 38)*
Low anterior resection 11 ± 3,5 (6 – 19)*
Hartmann’s operation 10 ± 2,9 (8 – 14)*
TABLE 9 - POSTOPERATIVE MORBIDITY OF ALL PA-
TIENTS (152).
* 18% of patients operated with abdominoperineal resection (Miles).
Complication Pts %
Abdominal wound infection 12 7,9
Anastomotic leak 11 7,2
Urinary tract complications 6 4
Pulmonary complications 5 3,3
Intraabdominal collections 4 2,6
Perineal wound infection* 4 2,6
Ileus 2 1,3
Postoperative haemorrhage 1 0,7
Total 45 30
TABLE 5 - MODIFIED ASTLER-COLLER CLASSIFICA-










TABLE 6 - PALLIATIVE SURGICAL TREATMENT OF REC-
TAL CANCER (46 PTS).
Procedure Pts %
Hartmann’s operation 34 74
Palliative colostomy 12 26
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dity, we made the local excision of tumor associated with
adjuvant therapy as a reasonable option of treatment with
good results and low recurrence rates  (19, 20). All our
patients were treated with adjuvant chemo- and ra-
diotherapy accordind to tumor stage and general con-
ditions. In some selected cases, chemoradiotherapy was
used succesfully to “downstage” unresectable cancers and
to treat them with surgery (21, 22).
Conclusion
The surgical treatment of rectal cancer has changed
radically in recent years in Albania. Relatively new sur-
gical techniques, like low anterior resection, and routi-
ne use of adjuvant chemoradiotherapy have improved the
outcome, quality of life and survival of our patients (2,
7, 10, 11, 14, 21, 22).
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